Treatment for Covid-19 using methylene blue and its side effects
Methylene Blue trials are being deprioritized as its a generic drug and has very low revenue potential
Global Trials to show successful results from Methylene Blue treatment
Methylene Blue when used for prophylaxis is a very potent drug for lung diseases. It has shown very promising results in Covid-19 trials and possibly is the only viable treatment in this pandemic.
Using Methylene Blue in nebulized form for treating patients with Coronavirus (Covid-19) As COVID-19(Coronavirus) ravages the world, a quick, novel, cost effective cure for this malaise needs to be found. Being a pulmonologist (lung specialist) in India, I have been treating pneumonia, other resp...
Dr Deepak Golwalkar is one of the senior most practising pulmonologist in India and his pioneering discovery of using Methylene Blue for lung diseases has been heralded as path breaking in the field of pulmonology.